Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow-derived MSC infusion for ALS (STR01-09)
jRCT2013190010Completed
- Sponsor
- Sapporo Medical University
- Start
- Sep 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Randomised, double-blind trial of autologous bone marrow derived mesenchymal stromal cells in amyotrophic lateral sclerosis (ALS) (2 arms), sponsored by Sapporo Medical University. Started Sep 2020; status: completed.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on jRCT2013190010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2013190010.